γDGG

Pricing Availability   Qty
说明: Broad spectrum glutamatergic antagonist
化学名: γ-D-Glutamylglycine
纯度: ≥99% (HPLC)
说明书
引用文献 (3)
评论 (1)
文献 (1)

生物活性 for γDGG

γDGG is a broad spectrum glutamate receptor antagonist.

技术数据 for γDGG

分子量 204.18
公式 C7H12N2O5
储存 Store at RT
纯度 ≥99% (HPLC)
CAS Number 6729-55-1
PubChem ID 6604701
InChI Key ACIJGUBIMXQCMF-SCSAIBSYSA-N
Smiles N[C@@]([H])([C@](O)=O)CCC(NCC(O)=O)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for γDGG

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
1eq. NaOH 100
water 20.42 100 温和加热

制备储备液 for γDGG

以下数据基于产品分子量 204.18。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 4.9 mL 24.49 mL 48.98 mL
5 mM 0.98 mL 4.9 mL 9.8 mL
10 mM 0.49 mL 2.45 mL 4.9 mL
50 mM 0.1 mL 0.49 mL 0.98 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for γDGG

分析证书/产品说明书
选择另一批次:

参考文献 for γDGG

参考文献是支持产品生物活性的出版物。

Aksenov et al (2005) Glutamate neurotransmission in the cerebellar interposed nuclei: involvement in classical conditioned eyeblinks and neuronal activity. J.Neurophysiol. 93 44 PMID: 15331619

Jones et al (1984) Structure-activity relations of dipeptide antagonists of excitatory amino acids. Neuroscience 13 573 PMID: 6392929


If you know of a relevant reference for γDGG, please let us know.

关键词: gammaDGG, gammaDGG supplier, Broad, spectrum, glutamate, receptor, antagonists, Ionotropic, Non-Selective, iGluR, Receptors, mGlur, Metabotropic, γDGG, gammaDGG, Non-selective, Glutamate, mGlu, 0112, Tocris Bioscience

3 篇 γDGG 的引用文献

引用文献是使用了 Tocris 产品的出版物。 γDGG 的部分引用包括:

Chen et al (2013) The Munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse. J Neurosci 33 8336 PMID: 23658173

Young and Neher (2009) Synaptotagmin has an essential function in synaptic vesicle positioning for synchronous release in addition to its role as a calcium sensor. Neuron 63 482 PMID: 19709630

Grueter et al (2008) In vivo metabotropic glutamate receptor 5 (mGluR5) antagonism prevents cocaine-induced disruption of postsynaptically maintained mGluR5-dependent long-term depression. J Neurosci 28 9261 PMID: 18784306


您是否知道使用了 Tocris γDGG 的优秀论文? 请告知我们.

γDGG 的评论

平均评分: 5 (Based on 1 Review.)

5 星
100%
4 星
0%
3 星
0%
2 星
0%
1 星
0%

Have you used γDGG?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


gamma-DGG impact on whole-cell response of cerebellar neuron.
By Anonymous on 06/07/2019
分析类型: Ex Vivo
种属: Rat
细胞系/组织: Cerebellum

Being added to perfusion solution at 0.5 mM concentration, gamma-DGG decreased electrical response amplitudes of pharmacologically isolated glutamate receptors in cerebellar neuron, and increased their paired-pulse ratio.

PMID: 23242311
review image

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.